Gastric Sleeve Surgery, or sleeve gastrectomy surgery, has been shown to benefit many co-morbidities including type 2 diabetes, hypertension, sleep apnea and more. Today we’re looking at just how well sleeve gastrectomy can benefit patients who have these conditions.
Type 2 Diabetes – 66% of patients have been cured, and about 20% Improved.
Hypertension – resolved in 88% of patients.
Obstructive Sleep Apnea – 87% resolved.
Other benefits often included in the group of bariatric surgery benefits are included below. But were not included in the published paper.
Quality of Life – 95% Improved!
Migraines – 57% resolved.
Pseudotumor Cerebri – 96% Resolved.
Dyslipidemia Hypercholesterolemia – 63% Resolved.
Non-Alcoholic Fatty Liver Disease – 90% Improved steatosis, 37% resolution of inflammation, 20% resolution of fibrosis.
Metabolic Syndrome – 83% resolved
Polycystic Ovarian Syndrome 79% resolution of hirsutism, 100% resolution of menstrual dysfunction
Venous Stasis Disease 95% resolved
Depression – 55% resolved.
Asthma 82% Improved or resolved.
Cardiovascular Disease 82% risk reduction/
GERD72-98% resolved.
Stress Univary Incontinence – 44-88% resolved.
Degenerative Joint Disease – 41-76% resolved
Gout 77% resolved
Mortality – 80% reduction in 5-year mortality.
References:
- Mervyn Deitel, Ross Crosby, Michel Gagner. The First International Consensus Summit for Sleeve Gastrectomy. Obesity Surgery. February 2008:
Related posts:
